Physician profile
Robert O Bigler
NPI 1023078441
$5,118.39
in general payments reported to CMS, 2019-2025
39 companies · $899 in 2025
The $899 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $309 · 2021: $799 · 2022: $759 · 2023: $683 · 2024: $1,334 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,499 · Travel and Lodging: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,499.24 |
| Travel and Lodging | $415.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $955.74 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Boston Scientific Corporation | $927.80 | 2020-2025 | Wavewriter Alpha Prime 16, Clinical Trial Product, General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $924.59 | 2019-2025 | Relistor, Trulance |
| Collegium Pharmaceutical, INC. | $392.20 | 2019-2025 | Xtampza, Belbuca |
| Abbott Laboratories | $324.26 | 2019-2024 | Proclaim |
| Radius Health, INC. | $213.16 | 2021-2025 | Tymlos |
| Arbor Pharmaceuticals, INC. | $154.11 | 2020-2021 | |
| Pfizer INC. | $144.43 | 2019-2025 | |
| Biodelivery Sciences International, INC. | $138.39 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $127.76 | 2025 | Breztri |
| Allergan, INC. | $67.87 | 2020-2022 | |
| Nevro Corp. | $53.63 | 2019-2024 | Senza |
| Almatica Pharma LLC | $47.40 | 2021 | |
| Redhill Biopharma INC. | $47.23 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $46.13 | 2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $40.40 | 2021 | |
| Scilex Pharmaceuticals INC. | $39.17 | 2020-2021 | |
| Grt US Holding, INC. | $36.44 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $36.23 | 2022 | |
| Mdd US Operations, LLC | $31.49 | 2019-2022 | |
| Lundbeck LLC | $27.96 | 2024 | Vyepti |
| Valinor Pharma, LLC | $27.49 | 2025 | Movantik |
| Saluda Medical Americas, INC. | $27.34 | 2024 | Evoke |
| Kyowa Kirin, INC. | $26.33 | 2023 | |
| Kaleo, INC. | $26.14 | 2019 | |
| Si-Bone, INC. | $22.35 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.06 | 2019 | |
| Tersera Therapeutics LLC | $19.95 | 2020 | |
| Amneal Pharmaceuticals LLC | $19.24 | 2022 | |
| Amgen INC. | $19.07 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.97 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $17.40 | 2024 | Exparel, Iovera |
| Bioventus LLC | $16.40 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.36 | 2019 | |
| Painteq LLC | $15.18 | 2023 | Painteq |
| Elutia, INC. | $14.59 | 2019 | |
| Pacira Therapeutics, INC. | $12.69 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.83 | 2022 | |
| Baudax Bio INC. | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bigler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.